Coronavirus 2-DG drug: Regulator nod cuts little ice with doctors; experts flag unreliable clinical data

Coronavirus 2-DG drug: Regulator nod cuts little ice with doctors; experts flag unreliable clinical data

However, as per the details uploaded on the trial registry only 40 patients participated in the phase 2 trials. Even as the central government has launched the 2-DG (2-deoxy-D-Glucose) drug which it has claimed reduces the recovery time and oxygen requirement of Coronavirus patients, a large section of experts and medical fraternity have expressed doubts … Read more

Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image) An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The drug, which was … Read more